# Primary Patency in Pediatric Patients With Hemodialysis Access

> **NCT06034717** · — · UNKNOWN · sponsor: **Alaa Gameil Abd El-salam Hussien** · enrollment: 60 (estimated)

## Conditions studied

- The Aim of This Study is to Follow up Short Term "3-6 Months"& Mid Term" 6-12months "Outcomes of Vascular Access" Native and Synthetic "in ESRD Pediatrics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06034717
- **Lead sponsor:** Alaa Gameil Abd El-salam Hussien
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-28
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06034717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06034717, "Primary Patency in Pediatric Patients With Hemodialysis Access". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06034717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*